214 related articles for article (PubMed ID: 30108358)
1. Funders must be wary of industry alliances.
Bauld L
Nature; 2018 Aug; 560(7718):283. PubMed ID: 30108358
[No Abstract] [Full Text] [Related]
2. Protecting NIH's Integrity and Trustworthiness in Public-Private Partnerships.
Lo B; Grady D
JAMA; 2018 Aug; 320(5):439-440. PubMed ID: 30088017
[No Abstract] [Full Text] [Related]
3. The academic/industry relationship: common misconceptions about bias.
Cugini M
J Dent Hyg; 2009; 83(4):208-9. PubMed ID: 19909651
[No Abstract] [Full Text] [Related]
4. Building relationships from an industry perspective.
Winston JL
J Dent Hyg; 2009; 83(4):204-5. PubMed ID: 19909649
[No Abstract] [Full Text] [Related]
5. The future of conflicts of interest: a call for professional standards.
Lo B
J Law Med Ethics; 2012; 40(3):441-51. PubMed ID: 23061572
[TBL] [Abstract][Full Text] [Related]
6. Exploring the government/industry interface--the NIH SBIR STTR program.
Etzler K
J Dent Hyg; 2009; 83(4):210-1. PubMed ID: 19909652
[No Abstract] [Full Text] [Related]
7. US advisers seek research overhaul.
Hand E
Nature; 2012 Dec; 492(7427):18. PubMed ID: 23222584
[No Abstract] [Full Text] [Related]
8. Funding bodies should foster partnerships between industry and academia.
Tzircotis G; Hickson T; Foulkes I
Nat Rev Cancer; 2021 Feb; 21(2):65-66. PubMed ID: 33398101
[No Abstract] [Full Text] [Related]
9. Industry Support of Medical Research: Important Opportunity or Treacherous Pitfall?
Tierney WM; Meslin EM; Kroenke K
J Gen Intern Med; 2016 Feb; 31(2):228-233. PubMed ID: 26307387
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease public-private partnerships: A landscape of the global nonprofit community.
Snyder HM; Bain LJ; Egge R; Carrillo MC
Alzheimers Dement; 2013 Jul; 9(4):466-71. PubMed ID: 23809367
[No Abstract] [Full Text] [Related]
11. No more third time lucky.
Ledford H
Nature; 2008 Oct; 455(7215):841. PubMed ID: 18923475
[No Abstract] [Full Text] [Related]
12. Peer review reviewed.
Nature; 2007 Sep; 449(7159):115. PubMed ID: 17851475
[No Abstract] [Full Text] [Related]
13. Financial conflicts of interest and the NIH.
Steinbrook R
N Engl J Med; 2004 Jan; 350(4):327-30. PubMed ID: 14736923
[No Abstract] [Full Text] [Related]
14. Corporate Funding for Schools of Public Health: Confronting the Ethical and Economic Challenges.
Bayer R; Sampat BN
Am J Public Health; 2016 Apr; 106(4):615-8. PubMed ID: 26890166
[TBL] [Abstract][Full Text] [Related]
15. Leveraging public private partnerships to innovate under challenging budget times.
Portilla LM; Rohrbaugh ML
Curr Top Med Chem; 2014; 14(3):326-9. PubMed ID: 24283971
[TBL] [Abstract][Full Text] [Related]
16. The best-kept secrets to winning grants.
Powell K
Nature; 2017 May; 545(7655):399-402. PubMed ID: 28541333
[No Abstract] [Full Text] [Related]
17. Hidden sources of private industry funding.
Resnik DB
Am J Bioeth; 2008 Aug; 8(8):60-1. PubMed ID: 18802869
[No Abstract] [Full Text] [Related]
18. An audience with...Francis Collins. Interviewed by Asher Mullard.
Collins F
Nat Rev Drug Discov; 2011 Jan; 10(1):14. PubMed ID: 21151031
[No Abstract] [Full Text] [Related]
19. Science on trial: conflicts of interest jeopardize scientific integrity and public health.
Krimsky S
Genewatch; 2003; 16(5):3-6. PubMed ID: 15025119
[No Abstract] [Full Text] [Related]
20. Exclusive: US National Science Foundation reveals first details on foreign-influence investigations.
Silver A
Nature; 2020 Jul; 583(7816):342. PubMed ID: 32641793
[No Abstract] [Full Text] [Related]
[Next] [New Search]
